Phospho-p27 Kip1 (Thr187) Monoclonal Antibody (2B10B7) - Citations

Phospho-p27 Kip1 (Thr187) Monoclonal Antibody (2B10B7) - Citations

View additional product information for Phospho-p27 Kip1 (Thr187) Monoclonal Antibody (2B10B7) - Citations (379700)

Showing 2 product Citations

Citations & References
Abstract
Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.
AuthorsLi W, Kotoshiba S, Berthet C, Hilton MB, Kaldis P,
JournalProc Natl Acad Sci U S A
PubMed ID19129496
'The G(1)/S-phase transition is a well-toned switch in the mammalian cell cycle. Cdk2, Cdk4, and the rate-limiting tumor suppressor retinoblastoma protein (Rb) have been studied in separate animal models, but interactions between the kinases and Rb in vivo have yet to be investigated. To further dissect the regulation of the ... More
Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
AuthorsChen Q, Xie W, Kuhn DJ, Voorhees PM, Lopez-Girona A, Mendy D, Corral LG, Krenitsky VP, Xu W, Moutouh-de Parseval L, Webb DR, Mercurio F, Nakayama KI, Nakayama K, Orlowski RZ,
JournalBlood
PubMed ID18305219
Decreased p27(Kip1) levels are a poor prognostic factor in many malignancies, and can occur through up-regulation of SCF(Skp2) E3 ligase function, resulting in enhanced p27 ubiquitination and proteasome-mediated degradation. While proteasome inhibitors stabilize p27(Kip1), agents inhibiting SCF(Skp2) may represent more directly targeted drugs with the promise of enhanced efficacy and ... More